Dolobid Tablet, Film Coated
Product Images NDC 74157-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dolobid (NDC 74157-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ina Pharmaceutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg-100s (250mg 100s)

250mg-100s (250mg 100s)
This text provides information about a medication called Dolobid, which contains Diflunisal, USP 250 mg per tablet. It includes details on the usual dosage, storage instructions, and precautions such as keeping the medication out of reach of children. The text also mentions the manufacturer, INA Pharmaceutics Inc., and provides manufacturing details. *
FDA Label Image

375mg-100s (375mg 100s)

375mg-100s (375mg 100s)
This excerpt provides information about a medication called Dolobid (Diflunisal) with each tablet containing 375 mg of Diflunisal, USP. The usual dosage instructions are advised to be checked in the package insert. The storage temperature range is specified as 20° to 25°C (68° to 77°F) with excursions allowed between 15° to 30°C (59° to 86°F). It emphasizes keeping the container tightly closed and out of reach of children. The medication is intended for prescription use only and comes in a package containing 60 tablets. Additionally, it mentions the need to dispense the Medication Guide to each patient. The product is manufactured for INA Pharmaceuticals Inc. in Fairmont, WV. The last revised date is given as 06/2024.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.